Meningococcal Group B Vaccine Market Report

Global Meningococcal Group B Vaccine Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：170
  • REPORT CODE：GMM839922
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Meningococcal Group B Vaccine market report explains the definition, types, applications, major countries, and major players of the Meningococcal Group B Vaccine market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pfizer

    • GSK

    By Type:

    • Type 1

    • Type 2

    By End-User:

    • Public

    • Private

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Meningococcal Group B Vaccine Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Meningococcal Group B Vaccine Outlook to 2028- Original Forecasts

    • 2.2 Meningococcal Group B Vaccine Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Meningococcal Group B Vaccine Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Meningococcal Group B Vaccine Market- Recent Developments

    • 6.1 Meningococcal Group B Vaccine Market News and Developments

    • 6.2 Meningococcal Group B Vaccine Market Deals Landscape

    7 Meningococcal Group B Vaccine Raw Materials and Cost Structure Analysis

    • 7.1 Meningococcal Group B Vaccine Key Raw Materials

    • 7.2 Meningococcal Group B Vaccine Price Trend of Key Raw Materials

    • 7.3 Meningococcal Group B Vaccine Key Suppliers of Raw Materials

    • 7.4 Meningococcal Group B Vaccine Market Concentration Rate of Raw Materials

    • 7.5 Meningococcal Group B Vaccine Cost Structure Analysis

      • 7.5.1 Meningococcal Group B Vaccine Raw Materials Analysis

      • 7.5.2 Meningococcal Group B Vaccine Labor Cost Analysis

      • 7.5.3 Meningococcal Group B Vaccine Manufacturing Expenses Analysis

    8 Global Meningococcal Group B Vaccine Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Meningococcal Group B Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Meningococcal Group B Vaccine Export by Region (Top 10 Countries) (2017-2028)

    9 Global Meningococcal Group B Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Meningococcal Group B Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)

    • 9.2 Global Meningococcal Group B Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Public Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Private Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Meningococcal Group B Vaccine Market Analysis and Outlook till 2022

    • 10.1 Global Meningococcal Group B Vaccine Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.2.2 Canada Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.2.3 Mexico Meningococcal Group B Vaccine Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.2 UK Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.3 Spain Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.4 Belgium Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.5 France Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.6 Italy Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.7 Denmark Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.8 Finland Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.9 Norway Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.10 Sweden Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.11 Poland Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.12 Russia Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.3.13 Turkey Meningococcal Group B Vaccine Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.2 Japan Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.3 India Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.4 South Korea Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.5 Pakistan Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.6 Bangladesh Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.7 Indonesia Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.8 Thailand Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.9 Singapore Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.10 Malaysia Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.11 Philippines Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.4.12 Vietnam Meningococcal Group B Vaccine Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.5.2 Colombia Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.5.3 Chile Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.5.4 Argentina Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.5.5 Venezuela Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.5.6 Peru Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.5.7 Puerto Rico Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.5.8 Ecuador Meningococcal Group B Vaccine Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.6.2 Kuwait Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.6.3 Oman Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.6.4 Qatar Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Meningococcal Group B Vaccine Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.7.2 South Africa Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.7.3 Egypt Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.7.4 Algeria Meningococcal Group B Vaccine Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Meningococcal Group B Vaccine Consumption (2017-2022)

      • 10.8.2 New Zealand Meningococcal Group B Vaccine Consumption (2017-2022)

    11 Global Meningococcal Group B Vaccine Competitive Analysis

    • 11.1 Pfizer

      • 11.1.1 Pfizer Company Details

      • 11.1.2 Pfizer Meningococcal Group B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pfizer Meningococcal Group B Vaccine Main Business and Markets Served

      • 11.1.4 Pfizer Meningococcal Group B Vaccine Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GSK

      • 11.2.1 GSK Company Details

      • 11.2.2 GSK Meningococcal Group B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GSK Meningococcal Group B Vaccine Main Business and Markets Served

      • 11.2.4 GSK Meningococcal Group B Vaccine Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    12 Global Meningococcal Group B Vaccine Market Outlook by Types and Applications to 2028

    • 12.1 Global Meningococcal Group B Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Meningococcal Group B Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Public Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Private Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Meningococcal Group B Vaccine Market Analysis and Outlook to 2028

    • 13.1 Global Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.2.2 Canada Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.2 UK Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.3 Spain Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.5 France Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.6 Italy Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.8 Finland Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.9 Norway Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.11 Poland Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.12 Russia Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.2 Japan Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.3 India Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.5.3 Chile Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.5.6 Peru Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.6.3 Oman Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Meningococcal Group B Vaccine Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Meningococcal Group B Vaccine

    • Figure of Meningococcal Group B Vaccine Picture

    • Table Global Meningococcal Group B Vaccine Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Meningococcal Group B Vaccine Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Type 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Type 2 Consumption and Growth Rate (2017-2022)

    • Figure Global Public Consumption and Growth Rate (2017-2022)

    • Figure Global Private Consumption and Growth Rate (2017-2022)

    • Figure Global Meningococcal Group B Vaccine Consumption by Country (2017-2022)

    • Table North America Meningococcal Group B Vaccine Consumption by Country (2017-2022)

    • Figure United States Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Canada Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Mexico Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Meningococcal Group B Vaccine Consumption by Country (2017-2022)

    • Figure Germany Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure UK Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Spain Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Belgium Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure France Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Italy Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Denmark Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Finland Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Norway Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Sweden Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Poland Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Russia Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Turkey Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Table APAC Meningococcal Group B Vaccine Consumption by Country (2017-2022)

    • Figure China Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Thailand Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Singapore Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Philippines Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Table South America Meningococcal Group B Vaccine Consumption by Country (2017-2022)

    • Figure Brazil Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Colombia Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Chile Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Argentina Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Peru Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Table GCC Meningococcal Group B Vaccine Consumption by Country (2017-2022)

    • Figure Bahrain Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Oman Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Qatar Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Table Africa Meningococcal Group B Vaccine Consumption by Country (2017-2022)

    • Figure Nigeria Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Africa Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Egypt Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Algeria Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Table Oceania Meningococcal Group B Vaccine Consumption by Country (2017-2022)

    • Figure Australia Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Meningococcal Group B Vaccine Consumption and Growth Rate (2017-2022)

    • Table Pfizer Company Details

    • Table Pfizer Meningococcal Group B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Meningococcal Group B Vaccine Main Business and Markets Served

    • Table Pfizer Meningococcal Group B Vaccine Product Portfolio

    • Table GSK Company Details

    • Table GSK Meningococcal Group B Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Meningococcal Group B Vaccine Main Business and Markets Served

    • Table GSK Meningococcal Group B Vaccine Product Portfolio

    • Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Public Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Private Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Meningococcal Group B Vaccine Consumption Forecast by Country (2022-2028)

    • Table North America Meningococcal Group B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Meningococcal Group B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Germany Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Meningococcal Group B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure China Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Meningococcal Group B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Brazil Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Meningococcal Group B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Meningococcal Group B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Meningococcal Group B Vaccine Consumption Forecast by Country (2022-2028)

    • Figure Australia Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Meningococcal Group B Vaccine Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US